COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 573: Articles 5721-5730  | Next

Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: An observational study
Olesen, T. B., Jensen, H., Moller, H., Jensen, J. W., Andersen, B., Vejborg, I., Njor, S. H.
10.1101/2022.09.26.22280381 — Posted: 2022-09-27
Comparative adverse effects, perceptions and attitudes related to BNT162b2, mRNA1273, or JNJ-78436735 SARS-CoV-2 vaccines: A population-based longitudinal cohort
Buerzle, O. V., Menges, D., Maier, J. D., Schams, D., Puhan, M. A., Fehr, J., Ballouz, T., Frei, A.
10.1101/2022.09.27.22280403 — Posted: 2022-09-27
Impact of Differential Vaccine Effectiveness on COVID-19 Hospitalization Cases: Projections for 10 Developed Countries where Booster Vaccines were Recommended
Maschio, M., Fust, K., Lee, A., Van de Velde, N., Buck, P. O., Kohli, M.
10.1101/2022.09.26.22280377 — Posted: 2022-09-27
Markovian Structures in Modeling COVID-19
Cui, E. H.
10.1101/2022.09.23.22280294 — Posted: 2022-09-27
Association of IFNAR2 rs2236757 and OAS3 rs10735079 polymorphisms with susceptibility to COVID-19 infection and severity
Abdelhafez, M., Nasereddin, A., Abu Shamma, O., Abed, R., Sinnokrot, R., Marof, O., Heif, T., Erekat, Z., Al-Jawabreh, A., Ereqat, s.
10.1101/2022.09.27.22280425 — Posted: 2022-09-27
Development and validation of a methodology to measure exhaled carbon dioxide (CO2) and control indoor air renewal
Baselga, M., Alba, J. J., Schuhmacher, A. J.
10.1101/2022.09.22.22280262 — Posted: 2022-09-27
Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program
Rao, S., Jing, N., Liu, X., Lorman, V., Maltenfort, M., Schuchard, J., Wu, Q., Tong, J., Razzaghi, H., Mejias, A., Lee, G. M., Pajor, N. M., Schulert, G. S., Thacker, D., Jhaveri, R., Christakis, D. A., Bailey, L. C., Forrest, C. B., Chen, Y.
10.1101/2022.09.26.22280364 — Posted: 2022-09-27
Comparison Of New and emerging SARS-CoV-2 variant Transmissibility through Active Contact Testing. A comparative cross-sectional household seroprevalence study.
Gaskell, K. M., El Kheir, N., Mirfenderesky, M., Rampling, T., Marks, M., Houlihan, C., Lemonge, N., Bristowe, H., Aslam, S., Kyprianou, D., Nastouli, E., Goldblatt, D., Fielding, K., Moore, D., CONTACT study team
10.1101/2022.09.27.22280419 — Posted: 2022-09-27
Presentation of long COVID and associated risk factors in a mobile health study
Stewart, C., Ranjan, Y., Conde, P., Sun, S., Rashid, Z., Sankesara, H., Cummins, N., Laiou, P., Bai, X., Dobson, R., Folarin, A.
10.1101/2022.09.27.22280404 — Posted: 2022-09-27
Evaluation of health system resilience in 60 countries based on their responses to COVID-19
Zhao, L., Jin, Y., Zhou, L., Yang, P., Qian, Y., Huang, X., Min, M.
10.1101/2022.09.25.22280337 — Posted: 2022-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).